{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:52Z","timestamp":1707525652182},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,20]]},"DOI":"10.7759\/cureus.50847","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T19:36:54Z","timestamp":1703101014000},"source":"Crossref","is-referenced-by-count":0,"title":["Late-Onset Masseteric Metastasis of Malignant Melanoma in a Patient With Neurofibromatosis and Lipomatosis: A Diagnostic Challenge and Case Report"],"prefix":"10.7759","author":[{"given":"Maria In\u00eas","family":"Borges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o M","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Ramalhosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sim\u00e3o","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Corte Real","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/medsci9040063","article-title":"Epidemiology of melanoma","volume":"9","author":"Saginala K","year":"2021","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A. Epidemiology of melanoma. Med Sci (Basel). 2021, 9:10.3390\/medsci9040063","journal-title":"Med Sci (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00827-6","article-title":"Signal pathways of melanoma and targeted therapy","volume":"6","author":"Guo W","year":"2021","unstructured":"Guo W, Wang H, Li C. Signal pathways of melanoma and targeted therapy. Signal Transduct Target Ther. 2021, 6:424. 10.1038\/s41392-021-00827-6","journal-title":"Signal Transduct Target Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9235638","article-title":"Immunotherapy in the treatment of metastatic melanoma: current knowledge and future directions","volume":"2020","author":"Ralli M","year":"2020","unstructured":"Ralli M, Botticelli A, Visconti IC, et al.. Immunotherapy in the treatment of metastatic melanoma: current knowledge and future directions. J Immunol Res. 2020, 2020:9235638. 10.1155\/2020\/9235638","journal-title":"J Immunol Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz411","article-title":"Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Michielin O","year":"2019","unstructured":"Michielin O, van Akkooi AC, Ascierto PA, Dummer R, Keilholz U. Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2019, 30:1884-901. 10.1093\/annonc\/mdz411","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis LE","year":"2019","unstructured":"Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019, 20:1366-79. 10.1080\/15384047.2019.1640032","journal-title":"Cancer Biol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-2012-2","article-title":"New paradigm for stage III melanoma: from surgery to adjuvant treatment","volume":"17","author":"Ascierto PA","year":"2019","unstructured":"Ascierto PA, Borgognoni L, Botti G, et al.. New paradigm for stage III melanoma: from surgery to adjuvant treatment. J Transl Med. 2019, 17:266. 10.1186\/s12967-019-2012-2","journal-title":"J Transl Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094561","article-title":"Prognostic and predictive biomarkers in stage III melanoma: current insights and clinical implications","volume":"22","author":"Tonella L","year":"2021","unstructured":"Tonella L, Pala V, Ponti R, et al.. Prognostic and predictive biomarkers in stage III melanoma: current insights and clinical implications. Int J Mol Sci. 2021, 22:4561. 10.3390\/ijms22094561","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115850","article-title":"Current understanding of neurofibromatosis type 1, 2, and schwannomatosis","volume":"22","author":"Tamura R","year":"2021","unstructured":"Tamura R. Current understanding of neurofibromatosis type 1, 2, and schwannomatosis. Int J Mol Sci. 2021, 22:5850. 10.3390\/ijms22115850","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2019.07.004","article-title":"The diagnosis and management of neurofibromatosis type 1","volume":"103","author":"Ly KI","year":"2019","unstructured":"Ly KI, Blakeley JO. The diagnosis and management of neurofibromatosis type 1. Med Clin North Am. 2019, 103:1035-54. 10.1016\/j.mcna.2019.07.004","journal-title":"Med Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2014.02.007","article-title":"Oral manifestations in patients with neurofibromatosis type-1: a comprehensive literature review","volume":"91","author":"Javed F","year":"2014","unstructured":"Javed F, Ramalingam S, Ahmed HB, et al.. Oral manifestations in patients with neurofibromatosis type-1: a comprehensive literature review. Crit Rev Oncol Hematol. 2014, 91:123-9. 10.1016\/j.critrevonc.2014.02.007","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius E","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, et al.. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021, 23:1506-13. 10.1038\/s41436-021-01170-5","journal-title":"Genet Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2020.0354","article-title":"The neurofibromatoses","volume":"117","author":"Farschtschi S","year":"2020","unstructured":"Farschtschi S, Mautner VF, McLean AC, Schulz A, Friedrich RE, Rosahl SK. The neurofibromatoses. Dtsch Arztebl Int. 2020, 117:354-60. 10.3238\/arztebl.2020.0354","journal-title":"Dtsch Arztebl Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0181","article-title":"Neoplasms associated with germline and somatic NF1 gene mutations","volume":"17","author":"Patil S","year":"2012","unstructured":"Patil S, Chamberlain RS. Neoplasms associated with germline and somatic NF1 gene mutations. Oncologist. 2012, 17:101-16. 10.1634\/theoncologist.2010-0181","journal-title":"Oncologist"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11072026","article-title":"Risk stratification and clinical characteristics of patients with late recurrence of melanoma (>10 years)","volume":"11","author":"Reschke R","year":"2022","unstructured":"Reschke R, Dumann K, Ziemer M. Risk stratification and clinical characteristics of patients with late recurrence of melanoma (>10 years). J Clin Med. 2022, 11:2026. 10.3390\/jcm11072026","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2019.09.011","article-title":"Role of surgery for metastatic melanoma","volume":"100","author":"Enomoto LM","year":"2020","unstructured":"Enomoto LM, Levine EA, Shen P, Votanopoulos KI. Role of surgery for metastatic melanoma. Surg Clin North Am. 2020, 100:127-39. 10.1016\/j.suc.2019.09.011","journal-title":"Surg Clin North Am"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpra.2016.07.001","article-title":"Isolated asymptomatic masseter muscle metastasis as first sign of metastatic disease in a patient with known melanoma","volume":"10","author":"Gjorup CA","year":"2016","unstructured":"Gjorup CA, Hendel HW, Svane IM, H\u00f6lmich LR. Isolated asymptomatic masseter muscle metastasis as first sign of metastatic disease in a patient with known melanoma. JPRAS Open. 2016, 10:1-4.","journal-title":"JPRAS Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-17-00045","article-title":"Lipomatous soft-tissue tumors","volume":"26","author":"Johnson CN","year":"2018","unstructured":"Johnson CN, Ha AS, Chen E, Davidson D. Lipomatous soft-tissue tumors. J Am Acad Orthop Surg. 2018, 26:779-88. 10.5435\/JAAOS-D-17-00045","journal-title":"J Am Acad Orthop Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7417\/CT.2020.2242","article-title":"Cutaneous manifestations in neurofibromatosis type 1","volume":"171","author":"Miraglia E","year":"2020","unstructured":"Miraglia E, Moliterni E, Iacovino C, Roberti V, Laghi A, Moramarco A, Giustini S. Cutaneous manifestations in neurofibromatosis type 1. Clin Ter. 2020, 171:e371-7. 10.7417\/CT.2020.2242","journal-title":"Clin Ter"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-13760-5","article-title":"Metastasectomy in stage IV melanoma: how and when should we employ it?","volume":"30","author":"Faries MB","year":"2023","unstructured":"Faries MB, Lowe M. Metastasectomy in stage IV melanoma: how and when should we employ it?. Ann Surg Oncol. 2023, 30:5312-3. 10.1245\/s10434-023-13760-5","journal-title":"Ann Surg Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2023.04.020","article-title":"Metastasectomy for metastatic melanoma in the era of effective systemic therapy","author":"Schwantes IR","year":"2023","unstructured":"Schwantes IR, Sutton T, Behrens S, Fowler G, Han G, Vetto JT, Han D. Metastasectomy for metastatic melanoma in the era of effective systemic therapy. Am J Surg. 2023, 10.1016\/j.amjsurg.2023.04.020","journal-title":"Am J Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/212462-late-onset-masseteric-metastasis-of-malignant-melanoma-in-a-patient-with-neurofibromatosis-and-lipomatosis-a-diagnostic-challenge-and-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:24Z","timestamp":1707509424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/212462-late-onset-masseteric-metastasis-of-malignant-melanoma-in-a-patient-with-neurofibromatosis-and-lipomatosis-a-diagnostic-challenge-and-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.50847","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,20]]}}}